Performance analysis of Ikena Oncology (IMA)
Annual Return
Over the past 3 years, IMA has had an average annual return of -57.04%, underperforming the benchmark SPY, which returned +19.62% annual.
Over the past 5 years, IMA has had an average annual return of -46.73%, underperforming the benchmark SPY, which returned +12.73% annual.
Since Mar 26, 2021, IMA has had an average annual return of -54.23%, underperforming the benchmark SPY, which returned +14.21% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -13.33% | -64.91% | -16.72% | -25.87% | -78.80% | -60.81% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +8.89% | -10.71% | -25.71% | +20.77% | -2.55% | +0.65% | +1.30% | -13.33% | |||||
| 2025 | -9.75% | -9.50% | -4.53% | -0.75% | -6.30% | +12.63% | +11.22% | -25.11% | -39.26% | +7.08% | -20.70% | +0% | -64.91% |
| 2024 | -31.98% | +6.68% | -0.67% | -6.98% | +33.90% | -6.69% | +1.74% | +1.71% | +1.31% | -1.29% | +1.31% | -5.18% | -16.72% |
| 2023 | +60.17% | -5.86% | -13.97% | +58.91% | +17.69% | +1.69% | -21.51% | -9.88% | -6.69% | -6.95% | -64.02% | +35.98% | -25.87% |
| 2022 | -22.40% | -37.22% | -0.16% | -36.36% | +0.49% | +13.54% | +14.23% | -6.14% | -25.27% | -22.54% | -18.86% | +19.23% | -78.80% |
| 2021 | -11.72% | -13.38% | -26.44% | -21.99% | -29.42% | +29.87% | -1.94% | -14.83% | +33.08% | -12.33% | -60.81% |
Drawdown analysis of Ikena Oncology (IMA)
The maximum drawdown for the IMA was -98.82%, occurring on Apr 6, 2026. This drawdown has not yet recovered.
The current IMA drawdown is -98.44%.
Since Mar 26, 2021 IMA has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.82% | Mar 26, 2021 | 1261 | Apr 6, 2026 | Ongoing | Ongoing | Ongoing |